City of Akron Backs Orthodata with $1.1 Million
The City’s Akron Development Corporation, through its Akron BioInvestment Funds, has invested $1.1 million in Orthodata, a Kentucky-based biomedical company that hopes to commercialize a new spine fusion sensor. Orthodata will also be relocating its headquarters to Akron.
4 April 2013•2 mins read
